Correlation Between NovaBay Pharmaceuticals and Compugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Compugen, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Compugen.

Diversification Opportunities for NovaBay Pharmaceuticals and Compugen

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NovaBay and Compugen is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Compugen go up and down completely randomly.

Pair Corralation between NovaBay Pharmaceuticals and Compugen

Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to under-perform the Compugen. But the stock apears to be less risky and, when comparing its historical volatility, NovaBay Pharmaceuticals is 1.37 times less risky than Compugen. The stock trades about -0.08 of its potential returns per unit of risk. The Compugen is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  72.00  in Compugen on September 1, 2024 and sell it today you would earn a total of  89.00  from holding Compugen or generate 123.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NovaBay Pharmaceuticals  vs.  Compugen

 Performance 
       Timeline  
NovaBay Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in NovaBay Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, NovaBay Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Compugen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

NovaBay Pharmaceuticals and Compugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NovaBay Pharmaceuticals and Compugen

The main advantage of trading using opposite NovaBay Pharmaceuticals and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.
The idea behind NovaBay Pharmaceuticals and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences